Process for preparation of pharmaceutical composition comprising VX478 and a water soluble vitamin E compound.
PK140581AUndetermined Publication Date: 2010-03-30GLAXO GROUP LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200801138
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-03-30
Abstract
Process for preparation of pharmaceutical composition containing HIV protease inhibitor, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141W94), and a tocopherol.
Need to check novelty before this filing date? Find Prior Art